tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

ZNTL Stock Latest News

Promising Potential and Strategic Positioning Justify Buy Rating for Zentalis Pharmaceuticals
RatingsPromising Potential and Strategic Positioning Justify Buy Rating for Zentalis Pharmaceuticals
2d ago
ZNTL
Zentalis Pharmaceuticals: Hold Rating Amid Market Challenges and Awaited Catalysts
PremiumRatings
Zentalis Pharmaceuticals: Hold Rating Amid Market Challenges and Awaited Catalysts
3d ago
ZNTL
Zentalis Pharmaceuticals: Hold Rating Amid Clinical Progress and Financial Uncertainty
PremiumRatings
Zentalis Pharmaceuticals: Hold Rating Amid Clinical Progress and Financial Uncertainty
5d ago
ZNTL
Zentalis Pharmaceuticals Reports Progress and Financials
PremiumCompany Announcements
Zentalis Pharmaceuticals Reports Progress and Financials
6d ago
ZNTL
Promising Potential of Zentalis Pharmaceuticals’ Azenosertib in Treating Platinum-Resistant Ovarian Cancer
PremiumRatings
Promising Potential of Zentalis Pharmaceuticals’ Azenosertib in Treating Platinum-Resistant Ovarian Cancer
6d ago
ZNTL
Zentalis files $250M mixed securities shelf
PremiumThe FlyZentalis files $250M mixed securities shelf
7d ago
ZNTL
Zentalis Highlights Promising Azenosertib Data at SGO 2025
Premium
Company Announcements
Zentalis Highlights Promising Azenosertib Data at SGO 2025
16d ago
8K
ZNTL
Positive Buy Rating for Zentalis Pharmaceuticals Driven by Promising Efficacy and Safety of Azenosertib in PROC Treatment
Premium
Ratings
Positive Buy Rating for Zentalis Pharmaceuticals Driven by Promising Efficacy and Safety of Azenosertib in PROC Treatment
16d ago
ZNTL
Zentalis presents updated clinical data on azenosertib as SGO 2025
PremiumThe Fly
Zentalis presents updated clinical data on azenosertib as SGO 2025
17d ago
ZNTL
ZNTL Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
ZNTL Upcoming Earnings Report: What to Expect?
1M ago
ZNTL
Zentalis price target lowered to $6 from $8 at Guggenheim
PremiumThe Fly
Zentalis price target lowered to $6 from $8 at Guggenheim
2M ago
ZNTL
Zentalis price target lowered to $6 from $8 at Wells Fargo
PremiumThe Fly
Zentalis price target lowered to $6 from $8 at Wells Fargo
2M ago
ZNTL
Zentalis price target lowered to $10 from $20 at H.C. Wainwright
PremiumThe FlyZentalis price target lowered to $10 from $20 at H.C. Wainwright
2M ago
ZNTL
Zentalis price target lowered to $10 from $20 at Oppenheimer
Premium
The Fly
Zentalis price target lowered to $10 from $20 at Oppenheimer
2M ago
ZNTL
Zentalis Pharmaceuticals Announces New Study for Azenosertib
Premium
Company Announcements
Zentalis Pharmaceuticals Announces New Study for Azenosertib
2M ago
8K
ZNTL
Zentalis presents updated clinical data on azenosertib
PremiumThe Fly
Zentalis presents updated clinical data on azenosertib
2M ago
ZNTL
Zentalis to reduce workforce by 40% in business restructuring
PremiumThe Fly
Zentalis to reduce workforce by 40% in business restructuring
2M ago
ZNTL
Zentalis Pharmaceuticals Restructures to Advance Oncology Product
PremiumCompany Announcements
Zentalis Pharmaceuticals Restructures to Advance Oncology Product
2M ago
8K
ZNTL
Lexeo Therapeutics appoints Rasbach as Chief Financial Officer
PremiumThe Fly
Lexeo Therapeutics appoints Rasbach as Chief Financial Officer
3M ago
LXEO
ZNTL
Zentalis appoints Chang as CPO, Wang as CBO
PremiumThe FlyZentalis appoints Chang as CPO, Wang as CBO
4M ago
ZNTL
Zentalis price target lowered to $8 from $12 at Guggenheim
Premium
The Fly
Zentalis price target lowered to $8 from $12 at Guggenheim
5M ago
ZNTL
Zentalis appoints Eastland as CEO, Bruns as CMO, Myers as Chairperson
Premium
The Fly
Zentalis appoints Eastland as CEO, Bruns as CMO, Myers as Chairperson
5M ago
MRK
ZNTL

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >